nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—P2RX4—peripheral nervous system—multiple sclerosis	0.0448	0.107	CbGeAlD
Suramin—P2RX4—nerve—multiple sclerosis	0.035	0.0831	CbGeAlD
Suramin—SIRT1—nerve—multiple sclerosis	0.0306	0.0728	CbGeAlD
Suramin—F2—leg—multiple sclerosis	0.0298	0.0708	CbGeAlD
Suramin—FSHR—cerebellum—multiple sclerosis	0.0119	0.0283	CbGeAlD
Suramin—SIRT5—medulla oblongata—multiple sclerosis	0.0111	0.0263	CbGeAlD
Suramin—P2RX4—medulla oblongata—multiple sclerosis	0.0105	0.0249	CbGeAlD
Suramin—P2RX4—spinal cord—multiple sclerosis	0.00933	0.0222	CbGeAlD
Suramin—SIRT1—medulla oblongata—multiple sclerosis	0.00917	0.0218	CbGeAlD
Suramin—PLA2G4A—Raltitrexed—Methotrexate—multiple sclerosis	0.00888	0.547	CbGdCrCtD
Suramin—RYR1—medulla oblongata—multiple sclerosis	0.00847	0.0201	CbGeAlD
Suramin—SIRT1—midbrain—multiple sclerosis	0.00838	0.0199	CbGeAlD
Suramin—SIRT5—nervous system—multiple sclerosis	0.00831	0.0198	CbGeAlD
Suramin—SIRT1—spinal cord—multiple sclerosis	0.00818	0.0194	CbGeAlD
Suramin—ARSA—spinal cord—multiple sclerosis	0.00808	0.0192	CbGeAlD
Suramin—SIRT5—central nervous system—multiple sclerosis	0.008	0.019	CbGeAlD
Suramin—P2RX4—nervous system—multiple sclerosis	0.00786	0.0187	CbGeAlD
Suramin—SIRT5—cerebellum—multiple sclerosis	0.00782	0.0186	CbGeAlD
Suramin—RYR1—midbrain—multiple sclerosis	0.00774	0.0184	CbGeAlD
Suramin—P2RX4—central nervous system—multiple sclerosis	0.00757	0.018	CbGeAlD
Suramin—P2RX4—cerebellum—multiple sclerosis	0.0074	0.0176	CbGeAlD
Suramin—SIRT1—nervous system—multiple sclerosis	0.00689	0.0164	CbGeAlD
Suramin—ARSA—nervous system—multiple sclerosis	0.0068	0.0162	CbGeAlD
Suramin—SIRT1—central nervous system—multiple sclerosis	0.00663	0.0158	CbGeAlD
Suramin—ARSA—central nervous system—multiple sclerosis	0.00655	0.0156	CbGeAlD
Suramin—SIRT1—cerebellum—multiple sclerosis	0.00648	0.0154	CbGeAlD
Suramin—ARSA—cerebellum—multiple sclerosis	0.0064	0.0152	CbGeAlD
Suramin—RYR1—nervous system—multiple sclerosis	0.00636	0.0151	CbGeAlD
Suramin—SIRT5—brain—multiple sclerosis	0.00635	0.0151	CbGeAlD
Suramin—RYR1—central nervous system—multiple sclerosis	0.00613	0.0146	CbGeAlD
Suramin—P2RX4—brain—multiple sclerosis	0.00601	0.0143	CbGeAlD
Suramin—RYR1—cerebellum—multiple sclerosis	0.00599	0.0142	CbGeAlD
Suramin—PLA2G2A—midbrain—multiple sclerosis	0.00587	0.0139	CbGeAlD
Suramin—SIRT1—brain—multiple sclerosis	0.00527	0.0125	CbGeAlD
Suramin—ARSA—brain—multiple sclerosis	0.0052	0.0124	CbGeAlD
Suramin—RYR1—brain—multiple sclerosis	0.00486	0.0116	CbGeAlD
Suramin—PLA2G2A—nervous system—multiple sclerosis	0.00482	0.0115	CbGeAlD
Suramin—PLA2G2A—central nervous system—multiple sclerosis	0.00464	0.011	CbGeAlD
Suramin—PLA2G4A—medulla oblongata—multiple sclerosis	0.00446	0.0106	CbGeAlD
Suramin—F2—spinal cord—multiple sclerosis	0.00432	0.0103	CbGeAlD
Suramin—PLA2G4A—midbrain—multiple sclerosis	0.00408	0.00969	CbGeAlD
Suramin—PLA2G4A—spinal cord—multiple sclerosis	0.00398	0.00946	CbGeAlD
Suramin—PLA2G2A—brain—multiple sclerosis	0.00369	0.00876	CbGeAlD
Suramin—F2—nervous system—multiple sclerosis	0.00364	0.00865	CbGeAlD
Suramin—F2—central nervous system—multiple sclerosis	0.00351	0.00833	CbGeAlD
Suramin—PLA2G4A—nervous system—multiple sclerosis	0.00335	0.00797	CbGeAlD
Suramin—PLA2G4A—central nervous system—multiple sclerosis	0.00323	0.00767	CbGeAlD
Suramin—F2—brain—multiple sclerosis	0.00278	0.00661	CbGeAlD
Suramin—PLA2G4A—brain—multiple sclerosis	0.00256	0.00609	CbGeAlD
Suramin—PLA2G4A—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000776	0.0477	CbGdCrCtD
Suramin—PLA2G4A—Betamethasone—Methylprednisolone—multiple sclerosis	0.000776	0.0477	CbGdCrCtD
Suramin—PLA2G4A—Dexamethasone—Betamethasone—multiple sclerosis	0.000764	0.047	CbGdCrCtD
Suramin—PLA2G4A—Betamethasone—Dexamethasone—multiple sclerosis	0.000764	0.047	CbGdCrCtD
Suramin—PLA2G4A—Dexamethasone—Triamcinolone—multiple sclerosis	0.000746	0.0459	CbGdCrCtD
Suramin—PLA2G4A—Betamethasone—Triamcinolone—multiple sclerosis	0.000746	0.0459	CbGdCrCtD
Suramin—PLA2G4A—Dexamethasone—Prednisone—multiple sclerosis	0.000708	0.0436	CbGdCrCtD
Suramin—PLA2G4A—Betamethasone—Prednisone—multiple sclerosis	0.000708	0.0436	CbGdCrCtD
Suramin—PLA2G4A—Dexamethasone—Prednisolone—multiple sclerosis	0.000691	0.0425	CbGdCrCtD
Suramin—PLA2G4A—Betamethasone—Prednisolone—multiple sclerosis	0.000691	0.0425	CbGdCrCtD
Suramin—F2—GPCR ligand binding—CCR2—multiple sclerosis	0.000346	0.000614	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IL6—multiple sclerosis	0.000345	0.000613	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—POMC—multiple sclerosis	0.000344	0.000612	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—S1PR1—multiple sclerosis	0.000342	0.000607	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000341	0.000606	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—TNF—multiple sclerosis	0.00034	0.000604	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CNR1—multiple sclerosis	0.000338	0.000601	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000334	0.000593	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—POMC—multiple sclerosis	0.000333	0.000591	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GPR65—multiple sclerosis	0.000332	0.000589	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CNR1—multiple sclerosis	0.000327	0.000581	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000325	0.000577	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—RPL5—multiple sclerosis	0.000324	0.000575	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.00032	0.000569	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CNR1—multiple sclerosis	0.000319	0.000567	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—VDR—multiple sclerosis	0.000319	0.000567	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—RGS1—multiple sclerosis	0.000318	0.000564	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—POMC—multiple sclerosis	0.000313	0.000556	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—IL6—multiple sclerosis	0.000308	0.000547	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CCL2—multiple sclerosis	0.000306	0.000544	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CXCL10—multiple sclerosis	0.000305	0.000541	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000303	0.000539	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CCR1—multiple sclerosis	0.000303	0.000539	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—POMC—multiple sclerosis	0.000302	0.000537	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GPR65—multiple sclerosis	0.000301	0.000535	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CCL2—multiple sclerosis	0.000295	0.000525	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CXCL10—multiple sclerosis	0.000294	0.000523	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000293	0.00052	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LINGO1—multiple sclerosis	0.000291	0.000517	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—RGS1—multiple sclerosis	0.00029	0.000516	CbGpPWpGaD
Suramin—F2—Hemostasis—ITGA4—multiple sclerosis	0.000287	0.000511	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CXCL10—multiple sclerosis	0.000287	0.00051	CbGpPWpGaD
Suramin—F2—Hemostasis—IFNB1—multiple sclerosis	0.000285	0.000507	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—TYK2—multiple sclerosis	0.000278	0.000494	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000275	0.000489	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GPR65—multiple sclerosis	0.000275	0.000489	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCL13—multiple sclerosis	0.000275	0.000489	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCR1—multiple sclerosis	0.000275	0.000489	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000275	0.000489	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000274	0.000487	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000274	0.000487	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—STAT3—multiple sclerosis	0.000271	0.000482	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—TYK2—multiple sclerosis	0.000268	0.000477	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CD86—multiple sclerosis	0.000266	0.000473	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LINGO1—multiple sclerosis	0.000266	0.000473	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ITGA4—multiple sclerosis	0.000263	0.000467	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCL5—multiple sclerosis	0.000262	0.000466	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IFNB1—multiple sclerosis	0.000261	0.000464	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CD86—multiple sclerosis	0.000257	0.000457	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP27B1—multiple sclerosis	0.000257	0.000456	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP24A1—multiple sclerosis	0.000257	0.000456	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—IL2—multiple sclerosis	0.000255	0.000452	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCL5—multiple sclerosis	0.000253	0.00045	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TAGAP—multiple sclerosis	0.000252	0.000448	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—MYC—multiple sclerosis	0.000252	0.000448	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000252	0.000447	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCR1—multiple sclerosis	0.000252	0.000447	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000252	0.000447	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000251	0.000446	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000251	0.000446	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CCL5—multiple sclerosis	0.000247	0.000439	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—MAPK1—multiple sclerosis	0.000246	0.000438	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—IL2—multiple sclerosis	0.000246	0.000437	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SPP1—multiple sclerosis	0.000243	0.000432	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—BCHE—multiple sclerosis	0.000237	0.000421	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—BCHE—multiple sclerosis	0.000237	0.000421	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCR5—multiple sclerosis	0.000236	0.00042	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GPC5—multiple sclerosis	0.000235	0.000417	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SPP1—multiple sclerosis	0.000235	0.000417	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.000234	0.000416	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL2RA—multiple sclerosis	0.000233	0.000414	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL2—multiple sclerosis	0.000231	0.000411	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TAGAP—multiple sclerosis	0.000231	0.00041	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000229	0.000406	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCR5—multiple sclerosis	0.000228	0.000406	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL2RA—multiple sclerosis	0.000225	0.0004	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000224	0.000397	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000223	0.000397	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL2—multiple sclerosis	0.000223	0.000397	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CCR5—multiple sclerosis	0.000223	0.000396	CbGpPWpGaD
Suramin—ARSA—Metabolism—APOE—multiple sclerosis	0.000221	0.000393	CbGpPWpGaD
Suramin—F2—Signaling Pathways—S1PR1—multiple sclerosis	0.000221	0.000392	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—APOE—multiple sclerosis	0.000215	0.000382	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GPC5—multiple sclerosis	0.000215	0.000381	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000208	0.000369	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—APOE—multiple sclerosis	0.000208	0.000369	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000204	0.000363	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—S1PR1—multiple sclerosis	0.000202	0.000358	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000201	0.000357	CbGpPWpGaD
Suramin—F2—Hemostasis—IL2RA—multiple sclerosis	0.000196	0.000349	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GPC5—multiple sclerosis	0.000196	0.000349	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCL3—multiple sclerosis	0.000196	0.000349	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000195	0.000347	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—RRM1—multiple sclerosis	0.000195	0.000346	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CD80—multiple sclerosis	0.000194	0.000345	CbGpPWpGaD
Suramin—ARSA—Metabolism—POMC—multiple sclerosis	0.00019	0.000338	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000189	0.000336	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CD80—multiple sclerosis	0.000188	0.000334	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RGS1—multiple sclerosis	0.000188	0.000333	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—POMC—multiple sclerosis	0.000185	0.000328	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000182	0.000324	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCL2—multiple sclerosis	0.000181	0.000321	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CNR1—multiple sclerosis	0.00018	0.00032	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IL2RA—multiple sclerosis	0.00018	0.000319	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000179	0.000319	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCL3—multiple sclerosis	0.000179	0.000319	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.000179	0.000318	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—POMC—multiple sclerosis	0.000178	0.000317	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GPR65—multiple sclerosis	0.000178	0.000316	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCR2—multiple sclerosis	0.000177	0.000315	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000177	0.000314	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000176	0.000312	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000175	0.00031	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCL2—multiple sclerosis	0.000175	0.00031	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000174	0.000309	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—POMC—multiple sclerosis	0.000174	0.000309	CbGpPWpGaD
Suramin—ARSA—Metabolism—ALB—multiple sclerosis	0.000173	0.000308	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000173	0.000307	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RGS1—multiple sclerosis	0.000172	0.000305	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000171	0.000303	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—MAPK1—multiple sclerosis	0.000171	0.000303	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CCL2—multiple sclerosis	0.00017	0.000303	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	0.000167	0.000297	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000167	0.000296	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TYK2—multiple sclerosis	0.000164	0.000292	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CNR1—multiple sclerosis	0.000164	0.000291	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCR1—multiple sclerosis	0.000163	0.000289	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCL13—multiple sclerosis	0.000163	0.000289	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GPR65—multiple sclerosis	0.000163	0.000289	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000162	0.000288	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCR2—multiple sclerosis	0.000162	0.000288	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000159	0.000283	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TYK2—multiple sclerosis	0.000159	0.000282	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000156	0.000278	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000151	0.000268	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CNR1—multiple sclerosis	0.00015	0.000266	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCL13—multiple sclerosis	0.000149	0.000264	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCR1—multiple sclerosis	0.000149	0.000264	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000147	0.000262	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—APOE—multiple sclerosis	0.000143	0.000253	CbGpPWpGaD
Suramin—F2—Hemostasis—ALB—multiple sclerosis	0.000142	0.000252	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CCL5—multiple sclerosis	0.00014	0.000248	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL2—multiple sclerosis	0.000137	0.000243	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL6—multiple sclerosis	0.000136	0.000241	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000135	0.00024	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000134	0.000238	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL2—multiple sclerosis	0.000132	0.000234	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL6—multiple sclerosis	0.000131	0.000233	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—ALB—multiple sclerosis	0.00013	0.000231	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.00013	0.00023	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MMP9—multiple sclerosis	0.000129	0.00023	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCL5—multiple sclerosis	0.000127	0.000225	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MYC—multiple sclerosis	0.000127	0.000225	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000126	0.000224	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MMP9—multiple sclerosis	0.000125	0.000222	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000124	0.00022	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—POMC—multiple sclerosis	0.000123	0.000218	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—POMC—multiple sclerosis	0.000122	0.000218	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CCL2—multiple sclerosis	0.00012	0.000213	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000118	0.00021	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCL5—multiple sclerosis	0.000116	0.000206	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL3—multiple sclerosis	0.000116	0.000206	CbGpPWpGaD
Suramin—F2—Hemostasis—IL2—multiple sclerosis	0.000115	0.000204	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—STAT3—multiple sclerosis	0.000115	0.000204	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCR5—multiple sclerosis	0.000114	0.000203	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000113	0.0002	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—BCHE—multiple sclerosis	0.000112	0.000198	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ALB—multiple sclerosis	0.000112	0.000198	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTGER4—multiple sclerosis	0.000112	0.000198	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—STAT3—multiple sclerosis	0.000111	0.000197	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PGR—multiple sclerosis	0.00011	0.000195	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCR3—multiple sclerosis	0.000108	0.000191	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MYC—multiple sclerosis	0.000107	0.00019	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CD28—multiple sclerosis	0.000107	0.00019	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TGFB1—multiple sclerosis	0.000107	0.000189	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL3—multiple sclerosis	0.000106	0.000188	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IL2—multiple sclerosis	0.000105	0.000187	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCR2—multiple sclerosis	0.000105	0.000186	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCR5—multiple sclerosis	0.000105	0.000186	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MAPK1—multiple sclerosis	0.000104	0.000186	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MYC—multiple sclerosis	0.000103	0.000183	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000103	0.000183	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TGFB1—multiple sclerosis	0.000103	0.000183	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTGER4—multiple sclerosis	0.000102	0.000181	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MAPK1—multiple sclerosis	0.000101	0.000179	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PGR—multiple sclerosis	0.0001	0.000179	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCR3—multiple sclerosis	9.85e-05	0.000175	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—POMC—multiple sclerosis	9.84e-05	0.000175	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CD28—multiple sclerosis	9.76e-05	0.000173	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CNR1—multiple sclerosis	9.67e-05	0.000172	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCR2—multiple sclerosis	9.59e-05	0.00017	CbGpPWpGaD
Suramin—F2—Hemostasis—TGFB1—multiple sclerosis	8.98e-05	0.00016	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—POMC—multiple sclerosis	8.94e-05	0.000159	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CNR1—multiple sclerosis	8.85e-05	0.000157	CbGpPWpGaD
Suramin—F2—Hemostasis—MAPK1—multiple sclerosis	8.81e-05	0.000156	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCL2—multiple sclerosis	8.74e-05	0.000155	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCL10—multiple sclerosis	8.71e-05	0.000155	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TGFB1—multiple sclerosis	8.21e-05	0.000146	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—POMC—multiple sclerosis	8.17e-05	0.000145	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—MAPK1—multiple sclerosis	8.05e-05	0.000143	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL6—multiple sclerosis	8.03e-05	0.000143	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCL2—multiple sclerosis	8e-05	0.000142	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCL10—multiple sclerosis	7.97e-05	0.000142	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—TYK2—multiple sclerosis	7.94e-05	0.000141	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL6—multiple sclerosis	7.75e-05	0.000138	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CD86—multiple sclerosis	7.62e-05	0.000135	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL5—multiple sclerosis	7.5e-05	0.000133	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—IL2—multiple sclerosis	7.27e-05	0.000129	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—TYK2—multiple sclerosis	7.26e-05	0.000129	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CD86—multiple sclerosis	6.97e-05	0.000124	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SPP1—multiple sclerosis	6.94e-05	0.000123	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL5—multiple sclerosis	6.86e-05	0.000122	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCR5—multiple sclerosis	6.75e-05	0.00012	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOE—multiple sclerosis	6.72e-05	0.000119	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL2RA—multiple sclerosis	6.66e-05	0.000118	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL2—multiple sclerosis	6.61e-05	0.000117	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SPP1—multiple sclerosis	6.35e-05	0.000113	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCR5—multiple sclerosis	6.18e-05	0.00011	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOE—multiple sclerosis	6.14e-05	0.000109	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL2RA—multiple sclerosis	6.09e-05	0.000108	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL2—multiple sclerosis	6.04e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—POMC—multiple sclerosis	5.77e-05	0.000103	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOE—multiple sclerosis	5.62e-05	9.98e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CD80—multiple sclerosis	5.56e-05	9.87e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—POMC—multiple sclerosis	5.28e-05	9.38e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ALB—multiple sclerosis	5.26e-05	9.35e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL2—multiple sclerosis	5.16e-05	9.18e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CD80—multiple sclerosis	5.08e-05	9.03e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MAPK1—multiple sclerosis	5.05e-05	8.98e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—POMC—multiple sclerosis	4.83e-05	8.58e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL2—multiple sclerosis	4.72e-05	8.39e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TYK2—multiple sclerosis	4.69e-05	8.33e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MAPK1—multiple sclerosis	4.62e-05	8.21e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TYK2—multiple sclerosis	4.29e-05	7.62e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL2—multiple sclerosis	3.9e-05	6.93e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6—multiple sclerosis	3.88e-05	6.9e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP9—multiple sclerosis	3.69e-05	6.56e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL2—multiple sclerosis	3.57e-05	6.34e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6—multiple sclerosis	3.55e-05	6.31e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP9—multiple sclerosis	3.38e-05	6e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—STAT3—multiple sclerosis	3.28e-05	5.83e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MYC—multiple sclerosis	3.05e-05	5.42e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TGFB1—multiple sclerosis	3.04e-05	5.41e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—STAT3—multiple sclerosis	3e-05	5.34e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAPK1—multiple sclerosis	2.99e-05	5.3e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MYC—multiple sclerosis	2.79e-05	4.96e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TGFB1—multiple sclerosis	2.78e-05	4.95e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAPK1—multiple sclerosis	2.73e-05	4.85e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6—multiple sclerosis	2.29e-05	4.08e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6—multiple sclerosis	2.1e-05	3.73e-05	CbGpPWpGaD
